Thyroid doses in Ukraine due to


Journal

Radiation and environmental biophysics
ISSN: 1432-2099
Titre abrégé: Radiat Environ Biophys
Pays: Germany
ID NLM: 0415677

Informations de publication

Date de publication:
11 2021
Historique:
received: 20 05 2021
accepted: 24 07 2021
pubmed: 6 8 2021
medline: 14 1 2022
entrez: 5 8 2021
Statut: ppublish

Résumé

This paper describes the revision of the thyroid dosimetry system in Ukraine using new, recently available data on (i) revised

Identifiants

pubmed: 34351497
doi: 10.1007/s00411-021-00930-w
pii: 10.1007/s00411-021-00930-w
pmc: PMC8551045
mid: NIHMS1744555
doi:

Substances chimiques

Iodine Radioisotopes 0
Iodine-131 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

591-609

Subventions

Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States

Informations de copyright

© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Références

Health Phys. 2014 Mar;106(3):370-96
pubmed: 25208014
Radiat Prot Dosimetry. 2003;105(1-4):593-9
pubmed: 14527033
Radiat Environ Biophys. 1994;33(2):149-66
pubmed: 7938438
Radiat Prot Dosimetry. 2013 Oct;156(4):407-23
pubmed: 23595409
Probl Radiac Med Radiobiol. 2020 Dec;25:285-299
pubmed: 33361841
Radiat Environ Biophys. 1998 Feb;36(4):261-73
pubmed: 9523343
Radiat Res. 2006 Jul;166(1 Pt 2):271-86
pubmed: 16808613
Radiat Environ Biophys. 2021 May;60(2):267-288
pubmed: 33661398
Radiat Prot Dosimetry. 2003;105(1-4):601-8
pubmed: 14527034
Health Phys. 2002 Feb;82(2):141-56
pubmed: 11797890
Health Phys. 2007 Nov;93(5):487-501
pubmed: 18049225
J Environ Radioact. 2005;84(3):343-62
pubmed: 16024139
Health Phys. 2002 Mar;82(3):290-303
pubmed: 11845832
Radiat Environ Biophys. 1996 May;35(2):81-7
pubmed: 8792454
Health Phys. 2011 Jun;100(6):583-93
pubmed: 22004928
Health Phys. 1993 Jun;64(6):594-9
pubmed: 8491614
Radiat Res. 2005 Feb;163(2):125-36
pubmed: 15658887
Health Phys. 2013 Jan;104(1):78-86
pubmed: 23192090

Auteurs

Sergii Masiuk (S)

State Institution "National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.

Mykola Chepurny (M)

State Institution "National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.

Valentyna Buderatska (V)

State Institution "National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.

Olga Ivanova (O)

State Institution "National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.

Zulfira Boiko (Z)

State Institution "National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.

Natalia Zhadan (N)

State Institution "National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.

Galyna Fedosenko (G)

State Institution "National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.

Andriy Bilonyk (A)

State Institution "National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.

Alexander Kukush (A)

Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.

Tatiana Lev (T)

Institute for Safety Problems of Nuclear Power Plants, National Academy of Sciences of Ukraine, Kyiv, Ukraine.

Mykola Talerko (M)

Institute for Safety Problems of Nuclear Power Plants, National Academy of Sciences of Ukraine, Kyiv, Ukraine.

Vladimir Drozdovitch (V)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Room 7E548 MSC 9778, Bethesda, MD, 20892-9778, USA. drozdovv@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH